DANIELLE BERUBE-RAUSCH: Open Payments
NPI 1699412056 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64 in 3 payments from 3 companies in 2025. Trend: 2023 $1,022 · 2024 $2,126 · 2025 $64
Food & beverage: $64
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $23 |
| Celgene Corporation | 1 | $21 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $20 |
Products named: KEYTRUDA, REBLOZYL, ZYNLONTA.
Industry payments across CT — which companies pay providers there.
